Results 61 to 70 of about 49,570 (201)

Fluoxetine does not influence response to continuous theta burst stimulation in human motor cortex

Neuropsychopharmacology Reports
Aim Selective serotonin reuptake inhibitors are thought to exert a clinical effect through various mechanisms, including through alteration in synaptic plasticity.
Duncan K. Austin, Lourenço M. D. Amador, Lucia M. Li, Simon J. Little, John C. Rothwell   +4 more
doaj   +1 more source

The Role of Selective Serotonin Reuptake Inhibitors in Premature Ejaculation

European Medical Journal, 2017
Premature ejaculation is a very common male sexual medical illness worldwide. Amongst several biological risk factors, the disturbance of central serotonin neurotransmission is one important cause.
Alka Aggarwal, Sunder Lal Jethani, RK Rohatgi, Juhi Kalra   +3 more
doaj  

Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery

São Paulo Medical Journal
BACKGROUND Stroke is the major cause of adult disability. Selective serotonin reuptake inhibitors (SSRIs) have been used for many years to manage depression. Recently, small trials have demonstrated that SSRIs might improve recovery after stroke, even in
Gillian E. Mead, Cheng-Fang Hsieh, Rebecca Lee, Mansur A. Kutlubaev, Anne Claxton, Graeme J. Hankey, Maree L. Hacklett   +6 more
doaj   +1 more source

Efficacy comparison of duloxetine and SSRIs at doses approved in Japan

Neuropsychiatric Disease and Treatment, 2015
Eiji Harada,1 Alexander Schacht,2 Tsukasa Koyama,3 Lauren Marangell,4,5 Toshinaga Tsuji,6 Rodrigo Escobar41Medical Science, Eli Lilly Japan K.K, Kobe, Japan; 2Global Statistical Sciences, Eli Lilly and Company, Bad Homburg, Germany; 3Clinical Research ...
Harada E, Schacht A, Koyama T, Marangell LB, Tsuji T, Escobar R   +5 more
doaj  

Case Report: Life-Threatening Fluoxetine-Linked Postoperative Bleeding Informed by Pharmacogenetic Evaluation

Drugs in R&D
Background Selective serotonin reuptake inhibitors (SSRI) are commonly used for the treatment of depression and anxiety. Inhibition of serotonin reuptake in platelets increases bleeding risk in patients taking SSRIs.
Sara Rogers, Patrick J. Silva, George Udeani, Monica Deleon, Sriarchala Mutyala, Ladan Panahi, Asim Abu-Baker, Gabriel Neal, Kenneth S. Ramos   +8 more
doaj   +1 more source

Supra-Therapeutic Selective Serotonin Reuptake Inhibitor (Ssri) Dosesfor Refractory Obsessive-Compulsive Disorder: A Case Report

Pakistan Armed Forces Medical Journal
response to standard first-line treatments. We report a case of treatment-refractory OCD that was successfully treated with the pharmacological strategy of using selective serotonin reuptake inhibitors (SSRIs) in the above-licensed doses.
Syed Faraz Zafar, Michelle Ahmed
doaj   +1 more source

Association of Selective Serotonin Reuptake Inhibitors With the Risk for Spontaneous Intracranial Hemorrhage

JAMA Neurology, 2017
C. Renoux, Sarah Vahey, S. Dell’Aniello, J. Boivin   +3 more
semanticscholar   +1 more source

Selective serotonin reuptake inhibitors. [PDF]

BMJ, 1992
Matthews, Keith, Eagles, John M.
  +9 more sources

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

British Journal of Psychiatry, 2001
M. Thase, A. Entsuah, R. Rudolph
semanticscholar   +1 more source

Bradycardia Caused by interaction of Venlafaxine and Cyclosporine: A case report

Caspian Journal of Internal Medicine, 2019
Background: Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are prescribed widely for the treatment of depression, anxiety disorders and other psychiatric disorders.
Marzieh Azizi, Forouzan Elyasi, fatemeh Niksolat Roodposhti   +2 more
doaj